Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients: a Phase IV, Double-blind, Placebo-controlled Study.
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2016
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 28 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Aug 2015 Planned End Date changed from 31 Dec 2015 to 1 Jun 2016, as reported by ClinicalTrials.gov record.
- 06 Aug 2015 Planned primary completion date changed from 31 Jul 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov record.